- Home
- BEAT vs AVX Comparison
BEAT vs AVX Comparison
Compare BEAT & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEAT | AVX |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | Canada |
| Employees | 16 | 3 |
| Industry | Retail: Computer Software & Peripheral Equipment | Metal Fabrications |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 63.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BEAT | AVX |
|---|---|---|
| Price | $1.14 | $0.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 804.6K | 403.0K |
| Earning Date | 03-12-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $530,767.50 |
| Revenue Next Year | $260.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.55 |
| 52 Week High | $4.00 | $2.27 |
Technical Indicators
Market Signals| Indicator | BEAT | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 34.24 | 40.03 |
| Support Level | $0.91 | $0.55 |
| Resistance Level | $1.35 | $0.81 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 4.54 | 6.83 |
Price Performance
Historical ComparisonAbout BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.